National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1393424

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1393424
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-03-12
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-06-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other      Purchased by: ??
Symptoms: Abortion spontaneous

Life Threatening? No
Birth Defect? Yes
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Folic acid supplementation; Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021619892

Write-up: Miscarriage; This is a spontaneous report from a contactable other health professional. This is a report received from the Regulatory Authority). The Regulatory authority report number is (GB-MHRA-WEBCOVID-202105271507133230-8N5QL) and the Safety Report Unique Identifier is (GB-MHRA-ADR 25372875). A 35-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on 12Mar2021 at single dose for COVID-19 immunization. Patient last menstrual period date was 02Mar2021. Perfectly fit and healthy. Patient had not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient was not enrolled in clinical trial. Patient was not currently breastfeeding. Medical history included pregnancy, patient no longer pregnant at the time of reporting, folic acid supplementation. Concomitant medication included folic acid for folic acid supplementation. The patient patient was exposed to the medicine first-trimester (1-12 weeks). The patient experienced miscarriage on an unspecified date in 2021. Serious criteria was reported as congenital anomaly. The outcome of the event was resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1393424&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166